{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:47:31Z","timestamp":1785894451334,"version":"3.56.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006458","name":"The Children\u2019s Hospital of Philadelphia Frontier Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The American Thyroid Association (ATA) Pediatric Guidelines recommend patients not receive radioactive iodine therapy (RAIT) for differentiated thyroid cancer (DTC) confined to the thyroid. Since publication, there is ongoing concern whether withholding RAIT will result in a lower rate of remission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study explores whether ATA low-risk patients treated with and without RAIT achieved similar remission rates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Medical records of patients &amp;lt;19 years old diagnosed with DTC and treated with total thyroidectomy between 2010 and 2020 were reviewed. Multivariate logistic regression was performed to evaluate factors influencing RAIT administration and remission rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ninety-five patients with ATA low-risk DTC were analyzed: 53% (50\/95) and 47% (45\/95) were treated with and without RAIT, respectively. RAIT was used to treat 82% of patients before 2015 compared with 33% of patients after 2015 (P &amp;lt; .01). No significant difference in 1-year remission rate was found between patients treated with and without RAIT, 70% (35\/50) vs 69% (31\/45), respectively. With longer surveillance, remission rates increased to 82% and 76% for patients treated with and without RAIT, respectively. Median follow-up was 5.8 years (IQR 4.3-7.9, range 0.9-10.9) and 3.6 years (IQR 2.7-6.6; range 0.9\u20139.3) for both cohorts. No risk factors for persistent or indeterminate disease status were found, including RAIT administration, N1a disease, and surgery after 2015.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Withholding RAIT for pediatric patients with ATA low-risk DTC avoids exposure to radiation and does not have a negative impact on remission rates. Dynamic risk stratification at 1-year after initial treatment is a suitable time point to assess the impact of withholding RAIT for these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad322","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T22:08:11Z","timestamp":1685743691000},"page":"3338-3344","source":"Crossref","is-referenced-by-count":21,"title":["Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy"],"prefix":"10.1210","volume":"108","author":[{"given":"Mya","family":"Bojarsky","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-9834","authenticated-orcid":false,"given":"Julia A","family":"Baran","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Halada","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Isaza","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"States","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"},{"name":"Section Oncologic Imaging, Department of Radiology, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick D","family":"Grant","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Robbins","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Sisko","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C","family":"Ricarte-Filho","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kazahaya","sequence":"additional","affiliation":[{"name":"Division of Pediatric Otolaryngology, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"},{"name":"Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N Scott","family":"Adzick","sequence":"additional","affiliation":[{"name":"Department of Surgery, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogol","family":"Mostoufi-Moab","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"},{"name":"Division of Oncology, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-881X","authenticated-orcid":false,"given":"Andrew J","family":"Bauer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"issue":"6","key":"2023111712384066000_dgad322-B1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/er.2011-0011","article-title":"The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy","volume":"32","author":"Rivkees","year":"2011","journal-title":"Endocr Rev"},{"issue":"18","key":"2023111712384066000_dgad322-B2","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"2023111712384066000_dgad322-B3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2023111712384066000_dgad322-B4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(18)30306-1","article-title":"Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial","volume":"7","author":"Dehbi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2023111712384066000_dgad322-B5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"issue":"2","key":"2023111712384066000_dgad322-B6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SLA.0000000000001688","article-title":"Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes?","volume":"265","author":"Adam","year":"2017","journal-title":"Ann Surg"},{"issue":"3","key":"2023111712384066000_dgad322-B7","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1530\/ERC-17-0453","article-title":"8th Edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2)","volume":"25","author":"Lamartina","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2023111712384066000_dgad322-B8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0042-1750334","article-title":"Applicability of adults 2015 American thyroid association differentiated thyroid cancer guidelines for postoperative risk stratification and postradioiodine treatment dynamic risk stratification in pediatric population","volume":"21","author":"Singh","year":"2022","journal-title":"World J Nucl Med"},{"issue":"2","key":"2023111712384066000_dgad322-B9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.2017.0214","article-title":"Practical initial risk stratification based on lymph node metastases in pediatric and adolescent differentiated thyroid cancer","volume":"28","author":"Jeon","year":"2018","journal-title":"Thyroid"},{"issue":"6","key":"2023111712384066000_dgad322-B10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.2021.0666","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"issue":"4","key":"2023111712384066000_dgad322-B11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4174\/astr.2018.95.4.222","article-title":"Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma","volume":"95","author":"Kim","year":"2018","journal-title":"Ann Surg Treat Res"},{"issue":"5","key":"2023111712384066000_dgad322-B12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jmoldx.2019.05.006","article-title":"Development and clinical validation of a large fusion gene panel for pediatric cancers","volume":"21","author":"Chang","year":"2019","journal-title":"J Mol Diagn"},{"issue":"1","key":"2023111712384066000_dgad322-B13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13073-019-0644-8","article-title":"Clinical utility of custom-designed NGS panel testing in pediatric tumors","volume":"11","author":"Surrey","year":"2019","journal-title":"Genome Med"},{"issue":"1","key":"2023111712384066000_dgad322-B14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/thy.2017.0059","article-title":"Molecular testing for oncogenic gene alterations in pediatric thyroid lesions","volume":"28","author":"Mostoufi-Moab","year":"2018","journal-title":"Thyroid"},{"issue":"12","key":"2023111712384066000_dgad322-B15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/dc.24564","article-title":"Multiplatform molecular test performance in indeterminate thyroid nodules","volume":"48","author":"Lupo","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"2023111712384066000_dgad322-B16"},{"issue":"43","key":"2023111712384066000_dgad322-B17","doi-asserted-by":"crossref","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"5","key":"2023111712384066000_dgad322-B18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"2023111712384066000_dgad322-B19","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2023111712384066000_dgad322-B20","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40(10)","author":"Franco","year":"2022;","journal-title":"J Clin Oncol"},{"key":"2023111712384066000_dgad322-B21","year":"2021"},{"issue":"22","key":"2023111712384066000_dgad322-B22","first-page":"2155","article-title":"Thyroidectomy without radioiodine in low-risk thyroid cancer","volume":"386","author":"Leboulleux","year":"2022","journal-title":"Reply. N Engl J Med"},{"issue":"3","key":"2023111712384066000_dgad322-B23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/a-0895-4997","article-title":"Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine","volume":"58","author":"Ajdari","year":"2019","journal-title":"Nuklearmedizin"},{"issue":"10","key":"2023111712384066000_dgad322-B24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1089\/thy.2018.0075","article-title":"Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer","volume":"28","author":"Zanella","year":"2018","journal-title":"Thyroid"},{"issue":"9","key":"2023111712384066000_dgad322-B25","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27226","article-title":"Differentiated thyroid cancer in children: heterogeneity of predictive risk factors","volume":"65","author":"Russo","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2023111712384066000_dgad322-B26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12020-017-1381-7","article-title":"Validation of dynamic risk stratification in pediatric differentiated thyroid cancer","volume":"58","author":"Sohn","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"2023111712384066000_dgad322-B27","first-page":"793","article-title":"Initial and dynamic risk stratification of pediatric patients with differentiated thyroid cancer","volume":"102","author":"Sung","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023111712384066000_dgad322-B28","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0180","article-title":"Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data","volume":"11","author":"Bauer","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"6","key":"2023111712384066000_dgad322-B29","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0146","article-title":"2022 ETA guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma","volume":"11","author":"Lebbink","year":"2022","journal-title":"Eur Thyroid J"},{"key":"2023111712384066000_dgad322-B30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2967\/jnumed.118.212449","article-title":"Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma","volume":"60","author":"Selvakumar","year":"2018","journal-title":"J Nucl Med"},{"issue":"13","key":"2023111712384066000_dgad322-B31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"2023111712384066000_dgad322-B32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/jc.2012-3401","article-title":"Papillary thyroid cancer: time course of recurrences during postsurgery surveillance","volume":"98","author":"Durante","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad322\/50626072\/dgad322.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/12\/3338\/53480983\/dgad322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/12\/3338\/53480983\/dgad322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:38:35Z","timestamp":1700228315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/12\/3338\/7188954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6,2]]},"published-print":{"date-parts":[[2023,11,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad322","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,6,2]]}}}